Quick Answer
Vericel Corp reported R&D Expense of $27.56 million for fiscal year 2025.
Vericel Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $27.56M | +11.2% |
| 2024 | $24.80M | +17.8% |
| 2023 | $21.04M | +5.5% |
| 2022 | $19.94M | +22.4% |
| 2021 | $16.29M | +25.1% |
| 2020 | $13.02M | -57.2% |
| 2019 | $30.39M | +123.5% |
| 2018 | $13.60M | +5.1% |
| 2017 | $12.94M | -15.4% |
| 2016 | $15.29M | -19.0% |
| 2015 | $18.89M | -11.2% |
| 2014 | $21.26M | +40.8% |
| 2013 | $15.10M | -42.0% |
| 2012 | $26.02M | +22.0% |
| 2011 | $21.33M | +68.5% |
| 2010 | $12.66M | +12.1% |
| 2009 | $11.29M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.32M | +3.7% | -6.1% |
| June 30, 2025 | $6.73M | -8.6% | -7.3% |
| March 31, 2025 | $7.26M | +13.1% | +19.2% |
| September 30, 2024 | $6.09M | +7.3% | -17.2% |
| June 30, 2024 | $7.36M | +40.2% | +14.7% |
| March 31, 2024 | $6.42M | +23.1% | +13.1% |
| September 30, 2023 | $5.68M | +12.5% | +8.1% |
| June 30, 2023 | $5.25M | +9.6% | +0.8% |
- Vericel Corp showed an increase of +11.2% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, Vericel Corp’s r&d expense has grown by 144.2% (from $11.29 million to $27.56 million).
- The most recent figure is from Vericel Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: